Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
For full access to this article login to GEN Select now.
Strategies for Optimizing Peptide Synthesis
Manufacturers Look for an Edge to Increase Purity and Lower Costs as Demand Grows
- The environmental impact of large-scale peptide production can be staggering. In his presentation at the “Avakado Media Peptide” conference held in April, Mimoun Ayoub, Ph.D., vp global business and strategic development at Peptisyntha (a Solvay company), noted that the production of 20 kilograms of an 18-residue peptide generates approximately ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.